Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04096001 · ClinicalTrials.gov registry record · Phase 1
Woebot for Substance Use Disorders
A Phase 1 study, sponsored by Woebot Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 101
- Enrollment target
NCT04096001 is a Phase 1 study that has completed, run by Woebot Health. The registered enrollment target is 101 participants.
The verdict
NCT04096001, a Phase 1 study, has completed, sponsored by Woebot Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 101 participants
- Enrollment target
Study Summary
Phase 1 of this study aims to develop a digitally-delivered substance use disorder program through the Woebot app-based platform (W-SUDs) and evaluate the effectiveness of, patient satisfaction with and the acceptability of W-SUDs as a substance use management tool.
Interventions
- DEVICE Woebot-SUDs (W-SUDs)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2020-03-26 |
| Est. Completion | 2020-08-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04096001
The ClinicalTrials.gov registry entry for NCT04096001 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Woebot Health, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Woebot-SUDs (W-SUDs) is the first listed.
NCT04096001 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04096001 about?
NCT04096001 is a clinical study titled "Woebot for Substance Use Disorders". Phase 1 of this study aims to develop a digitally-delivered substance use disorder program through the Woebot app-based platform (W-SUDs) and evaluate the effectiveness of, patient satisfaction with and the acceptability of W-SUDs as a substance use management tool.
What is the current status of trial NCT04096001?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 101 participants. The study started on 2020-03-26. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT04096001?
The interventions under investigation include: Woebot-SUDs (W-SUDs) (DEVICE).
Who is sponsoring clinical trial NCT04096001?
This trial is sponsored by Woebot Health, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.